Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients ...
Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...
We found the following factors were important for predicting the progression of glaucoma: (1) the presence of small bleeding and poor blood flow to the retina and back of the eye, (2) abnormal cell ...
A new analysis linking clinical and census data finds individual factors, rather than neighborhood conditions, are more strongly associated ...
Researchers have found in a new study that personal wealth is strongly associated with outcomes 12–18 months after a new ...
DEAR DR. ROACH: I am a 77-year-old woman in good health. I walk daily. The only prescribed medications I am on are two different eye drops for glaucoma. My eye pressure is under control; I have it ...
Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the ...
The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback